Come up with a name for your new list and we'll add to it:
Tekmira Pharmaceuticals raised a round of funding on , . Investors include
BDC Healthcare Venture Fund.
Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira's three lead RNA…